Add this result to my export selection Revised SPCs: Lynparza (olaparib) – all strengths Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 13 November 2020 SPC updated with additional indication - for the first-line maintenance treatment of homologous recombination deficiency (HRD)-positive advanced ovarian cancer in combination with bevacizumab. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Forxiga (dapagliflozin) – all presentations Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 13 November 2020 SPC –details license extension for use in symptomatic chronic heart failure with reduced ejection fraction in adults. Dapagliflozin has not been studied for the treatment of heart failure in pts with... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Granpidam (sildenafil) 20 mg film-coated tablets Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 13 November 2020 SPC advises that sildenafil should not be used in neonates with persistent pulmonary hypertension of the newborn as risks outweigh the benefits. The safety and efficacy of sildenafil in other... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Zyban (buproprion) 150 mg prolonged release tablets Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 13 November 2020 SPC warns of risk of serotonin syndrome when co-administered with selective serotonin reuptake inhibitors/serotonin norepinephrine re-uptake inhibitors. If concomitant treatment is required, careful... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Transtec (buprenorphine) transdermal patch- all strengths Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 29 October 2020 Following PRAC recommendation, SPCs now include warning that concomitant administration with other serotonergic agents, such SSRIs, SNRIs) or tricyclic antidepressants may result in serotonin... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Humulin (human insulin) products Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 29 October 2020 SPCs now advise that patients must be instructed to perform continuous rotation of the injection site to reduce the risk of developing lipodystrophy and cutaneous amyloidosis, which can lead to... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Ranexa (ranolazine) prolonged-release Tablets- all strengths Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 29 October 2020 Myoclonus has been added to SPC as an adverse event of unknown frequency. The SPC has also been updated to advise that in postmarketing experience, there have been reports of intentional overdose of... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Ferinject (ferric carboxymaltose) Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 04 November 2020 SPC now warns that symptomatic hypophosphataemia leading to osteomalacia and fractures requiring clinical intervention including surgery has been reported in the post marketing setting. Patients... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Phenergan (promethazine) tablets- all strenghts Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 04 November 2020 Restless legs syndrome has been added to SPC as adverse effect. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Kigabeq (vigabatrin) 100 and 500 mg soluble tablets Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 04 November 2020 Insomnia and alopecia (frequency “common”) and reduced visual acuity (frequency “not known”) have been to SPC as adverse effects. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)